Skip to main content
. 2015 Jul 28;5:10648. doi: 10.1038/srep10648

Figure 3.

Figure 3

Kaplan–Meier estimates of (A) progression-free survival (PFS) and (B) overall survival (OS) in NSCLC patients, stratified by EGFR mutations status.